Kronos Bio, Inc. Quarterly Operating Lease, Payments in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kronos Bio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q3 2019 to Q2 2024.
  • Kronos Bio, Inc. Operating Lease, Payments for the quarter ending June 30, 2024 was $1.1M, a 26.7% decline year-over-year.
  • Kronos Bio, Inc. Operating Lease, Payments for the twelve months ending June 30, 2024 was $5.7M, a 3.39% decline year-over-year.
  • Kronos Bio, Inc. annual Operating Lease, Payments for 2023 was $5.6M, a 1.75% decline from 2022.
  • Kronos Bio, Inc. annual Operating Lease, Payments for 2022 was $5.7M, a 29.5% increase from 2021.
  • Kronos Bio, Inc. annual Operating Lease, Payments for 2021 was $4.4M, a 57.1% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.7M $1.1M -$400K -26.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $6.1M $1.4M +$500K +55.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $5.6M $1.9M +$300K +18.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $5.3M $1.3M -$600K -31.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.9M $1.5M +$300K +25% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $5.6M $900K -$100K -10% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5.7M $1.6M +$600K +60% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $5.1M $1.9M +$900K +90% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $4.2M $1.2M $0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $4.2M $1M -$200K -16.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $4.4M $1M -$500K -33.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $4.9M $1M +$300K +42.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $4.6M $1.2M +$700K +140% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $3.9M $1.2M +$1.1M +1100% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $2.8M $1.5M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $700K +$600K +600% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $500K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $100K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $100K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.